Therapy Areas: Autoimmune
6 September 2019 - - US-based biopharmaceutical company Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) has received final topline results from its recently completed dose-ranging Phase 2 trial eval...
6 September 2019 - - Chinese biopharmaceutical company Genor Biopharma has named Jack Hu as Chief Financial Officer and Chief Strategy Officer, the company said.
Before joining Genor, Dr. Hu ser...
4 September 2019 - Pharmaceutical company Calliditas Therapeutics AB on Tuesday provided an update of the ongoing pivotal Phase 3 NefIgArd study with its leading drug candidate Nefecon for the chronic...
30 August 2019 - - US-based biotherapeutics developer HiFiBiO Therapeutics has closed a USD 67m Series C financing round. The funding was led by new investor IDG Capital, the company said.
...
30 August 2019 - HiFiBiO Therapeutics, a US biotherapeutics company, has completed a USD67m Series C financing round, it was reported yesterday.The funding was headed by new investor, IDG Capital. The...